Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study
Research output: Contribution to journal › Journal article › Research › peer-review
We examined whether plasma C-reactive protein (CRP) levels at the time of diagnosis of breast cancer are associated with overall survival, disease-free survival, death from breast cancer, and recurrence of breast cancer.
|Journal||Breast Cancer Research (Online Edition)|
|Publication status||Published - 2011|